The role of JAK/STAT signaling pathway and its inhibitors in diseases - PubMed (original) (raw)

Review

The role of JAK/STAT signaling pathway and its inhibitors in diseases

Ping Xin et al. Int Immunopharmacol. 2020 Mar.

Abstract

The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway and involved in many crucial biological processes, including cell proliferation, differentiation, apoptosis, and immune regulation. It provides a direct mechanism for extracellular factors-regulated gene expression. Current researches on this pathway have been focusing on the inflammatory and neoplastic diseases and related drug. The mechanism of JAK/STAT signaling is relatively simple. However, the biological consequences of the pathway are complicated due to its crosstalk with other signaling pathways. In addition, there is increasing evidence indicates that the persistent activation of JAK/STAT signaling pathway is closely related to many immune and inflammatory diseases, yet the specific mechanism remains unclear. Therefore, it is necessary to study the detailed mechanisms of JAK/STAT signaling in disease formation to provide critical reference for clinical treatments of the diseases. In this review, we focus on the structure of JAKs and STATs, the JAK/STAT signaling pathway and its negative regulators, the associated diseases, and the JAK inhibitors for the clinical therapy.

Keywords: JAK/STAT pathway and diseases; JAK/STAT signaling pathway; JAKs inhibitors and diseases; Negative regulators.

Copyright © 2020 Elsevier B.V. All rights reserved.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflict of interest.

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources